PRESS RELEASE: Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy, today announced that the first patients have been treated...
Scientists have had limited success at identifying specific inherited genes associated with prostate cancer. Researchers at University of Utah Health studied prostate cancer patients with multiple cancer diagnoses to identify genetic mutations that may influence cancer treatment and cancer risk.
Activation of the PTEN–PI3K–mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation. Here we show that mechanistic target of rapamycin complex 1 (mTORC1) regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. Show More Summary
A way to make sense of the shifting advice by experts.
DEAR MAYO CLINIC: I am 63 and was diagnosed with prostate cancer two years ago. I had my prostate removed shortly after the diagnosis. I found out recently the cancer is now in my lymph nodes. What can I do to prevent it from spreading further? ANSWER: When prostate cancer spreads out of the prostate gland, […]
The anchor made the announcement on air.
(Cleveland Clinic) Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Show More Summary
The excellent results are in from a two-year study from Europe concerning single-dose iridium therapy for prostate cancer. The post Single-Dose Radiation Found Effective for Prostate Cancer appeared first on ExtremeTech.
PRESS RELEASE: Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy, today announced that the first patient in New Zealand...
Two studies have confirmed that it's time to stop edging and start cumming.
Ejaculating more could lower your risk of prostate cancer and may make you generally healthier, according to researchers. A 2016 study found that from a sample of 32,000 men followed over a number of years, participants in their 20s who ejaculated 21 times per month or more were 19 percent less likely to develop prostate […]
Immunotherapy is an emerging treatment for cancer that aims to boost the immune system cells' ability to fight off cancer. Learn more in this article.
Straight out of sci-fi and coming soon to your hometown medical school, this technique exploits a physical property so fundamental that it almost looks low-tech. The post Force Fields Become a Weapon in the Fight Against Prostate Cancer appeared first on ExtremeTech.
For prostate and penile cancer, scientists have developed an implant the size of a grain of rice that can deliver targeted radiation to the problem area and nowhere else. The post This Tiny Radioactive Implant is a Powerhouse for Treating Prostate Cancer appeared first on ExtremeTech.
Revolutionary three-in-one blood test could change treatment for advanced stages of disease, say scientists. A new three-in-one blood test could pave the way to precision-personalised treatment for advanced prostate cancer, say scientists. Show More Summary
Three-in-one test reveals which men with advanced cancer are suitable for treatment with ‘precision’ drug olaparib Scientists have developed a simple three-in-one blood test they believe could transform treatment of advanced prostate cancer, helping to extend or save lives. Show More Summary
A single blood test could identify how prostate cancer patients will respond to PARP inhibitors in as little as 4 to 8 weeks, say researchers.
Researchers have found that a compound in apple peel can prevent the growth of prostate cancer cells when combined with turmeric or red grape compounds.
(Institute of Cancer Research) Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes. By testing cancer...Show More Summary
By GEORGE BERGER, PHD I was diagnosed with aggressive but localized prostate cancer at a major Dutch academic hospital. My parameters were PSA 29 or 31, Gleason sum 4 + 4, and stage T2c. Fortunately, there were no detectable distant metastases. The specialist drew a simple image of my urinary tract and told me I